Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local levobupivacaine for pain relief after esophageal ESD
NL-OMON59603Phase 4Recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levobupivacaine in postprocedural pain (CPSP) (2 arms), sponsored by St. Antonius Ziekenhuis. Primary endpoint: Proportion of patients with major pain within 90 minutes after the procedure. Started Oct 2024; status: recruiting.
02
Drugs
levobupivacaine
03
Conditions
postprocedural pain (CPSP)
Beyond the preview
Go deeper on NL-OMON59603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59603.